key: cord-1026063-2hi6etgp authors: Florin, Luise; de Winde, Charlotte M. title: Recent advancements in the understanding of tetraspanin functions date: 2020-07-23 journal: Med Microbiol Immunol DOI: 10.1007/s00430-020-00687-x sha: dec2e540a4cf2f9e0f9a0218ed946a39c5827b66 doc_id: 1026063 cord_uid: 2hi6etgp nan The spatiotemporal coordination of transmembrane proteins plays an important role in an exceptionally wide range of cellular activities, including in all steps of pathogen infection as well as immunological processes. Tetraspanin proteins are the master organizers of membrane proteins, and are therefore involved in physiological and pathophysiological processes, as presented in this special issue "Tetraspanins in Infection and Immunity". These transmembrane proteins span the membrane four times and form extended subdomains by means of their strong tendency to associate laterally with one another and with different classes of proteins, such as cell surface receptors, immunoglobulins, adhesion and signalling molecules, and proteases [1] . As such, they anchor specific proteins to one site on the cell membrane forming microclusters that then further organize into larger assemblies, the so-called tetraspanin-enriched microdomains. These microdomains enable membrane dynamics, like endocytosis, recycling, exocytosis, cell motility, fusion and signalling. The role of tetraspanins in cell fusion, for example, is described in mammalian reproductive processes and development [2] . Because of their involvement in a wide range of cellular processes, tetraspanins are exploited by many pathogens such as viruses and bacteria during their entry and egress. In addition, dysregulation of normal tetraspanin function leads to diseases like cancer, diabetes, Alzheimer's and autoimmune reactions [3, 4] . This, coupled with their easy accessibility as membrane proteins, means that tetraspanins have a huge potential to serve as therapeutic targets for the development of new treatments in cancer, hematological malignancies and infectious diseases [5] [6] [7] [8] . In recent years, it became apparent that tetraspanins define entry sites of hepatitis C virus (HCV), human papilloma virus (HPV), coronavirus, influenza A virus, and human immunodeficiency virus by organizing receptors and other components into viral entry platforms [9, 10] . In this issue, five research studies deepen our understanding of the role of tetraspanins in bacterial and viral infections. Super-resolution and confocal imaging analyses suggest that contact of HPV16 particles with the cell surface triggers the formation of large three-dimensional tetraspanin architectures that contain at least two different tetraspanins, CD151 and CD63, and are connected to filamentous actin [11] . In the same virus and cell system, additional tetraspanins like CD9 not necessarily support infection, but act as negative regulators of the invasion process [12] . In this study, comparative analyses using CD9 low-or high-expressing cells suggest that a specific tetraspanin expression optimum promotes the entry process of the pathogen. The inhibitory role of CD9 and CD81 during pathogen infection is also shown by Elgawidi and colleagues [13] . Burkholderia thailandensis is able to induce the formation of multinucleated giant cells where these tetrapanins are involved. The authors used tetraspanin antibodies and recombinant proteins corresponding to the large extracellular domain of the tetraspanins to modulate their function. They show that antibodies against CD9 and CD81 enhanced the cell-cell fusion process induced by the bacterium whereas recombinant tetraspanin proteins acted in an inhibitory way. In addition to their function in plasma membrane processes, tetraspanins also regulate intracellular processes by the modulation of signalling pathways [1] . Benayas and colleagues show that the loss of CD81 on herpes simplex virus type-1 infected cells compromised replication of viral DNA and formation of new infectious particles [14] . The relevance of tetraspanins in naturally occurring infections and their outcome is additionally supported by the study of Alberione et al. [15] . They provide evidence that genetic host-variation contributes to inter-individual differences in HCV infection and outcome. Tetraspanins are involved in many aspects of immunity, and as such play a pivotal role in establishing an effective immune response [16] [17] [18] . Further overview articles in this special issue highlight that tetraspanins control different stages of the migration of dendritic cells, which engulf and present antigens to initiate an immune response, from the site of infection to the lymph node [19] . On mast cells, important in antiviral responses and hyperactive in patients with allergies, tetraspanins control release of intracellular granules with immunomodulatory compounds by membrane remodelling [20] . Two tetraspanins, CD37 and CD53, are exclusively expressed on immune cells [21] . The role of CD37 has been studied extensively in the past two decades, but studies investigating the function of CD53 have only emerged in recent years. In this issue, Dunlock has provided a detailed review on the multifunctional role of CD53 in the immune system, controlling immune cell adhesion and migration, and intracellular signalling pathways [22] . New functional roles for tetraspanins are continuously being discovered, and possibilities for targeting tetraspanins in diseases are emerging. McLaughlin and colleagues review an important role for Tspan7 in the autoimmune response in type 1 diabetes, and propose targeting Tspan7 as a promising strategy to prevent disease [4] . Furthermore, Gavin and colleagues present in this issue Tspan18 as a new regulator of calcium signalling in activated endothelial cells, thereby controlling thrombo-inflammation in acute organ damage upon ischaemic stroke and venous thrombosis [23] . Targeting Tspan18 may be a better potential therapeutic strategy to interfere with endothelial function than targeting Orai1 which is widely expressed on a diverse range of cell types. Tetraspanin biology is intensively studied since the discovery of this protein family in the mid 1980s, and has developed into a hot topic with several interfaces between structural molecular biology and a variety of diseases. New imaging technologies, such as superresolution microscopy or simulations of molecular dynamics, in combination with functional analysis now enable scientists to understand key mechanisms in the formation of tetraspanin-enriched microdomains and tetraspanin-regulated processes. This will significantly contribute to the discovery of promising tetraspanin targets to treat infections, immunological pathologies, and other diseases. The aim of this special issue is to update the reader in the latest findings concerning the function of tetraspanins in different physiological and pathological situations, focussing on infection and immunity. Acknowledgements Open Access funding provided by Projekt DEAL. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. Tetraspanins: integrating cell surface receptors to functional microdomains in homeostasis and disease Tetraspanins in mammalian reproduction: spermatozoa, oocytes and embryos Tetraspanin 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity, diabetes and cancer Autoimmunity to tetraspanin-7 in type 1 diabetes Tetraspanins as therapeutic targets in hematological malignancy: a concise review Inhibition of tetraspanin functions impairs human papillomavirus and cytomegalovirus infections CD81 is a novel immunotherapeutic target for B cell lymphoma TSPAN8 as a novel emerging therapeutic target in cancer for monoclonal antibody therapy Tetraspanin assemblies in virus infection Tetraspanins: architects of viral entry and exit platforms HPV caught in the tetraspanin web? Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway A role for tetraspanin proteins in regulating fusion induced by Burkholderia thailandensis Tetraspanin CD81 regulates HSV-1 infection Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells Tetraspanins as organizers of antigen-presenting cell function Expression and function of tetraspanins and their interacting partners in B cells The many and varied roles of tetraspanins in immune cell recruitment and migration Molecular mechanisms of dendritic cell migration in immunity and cancer Tetraspanins in the regulation of mast cell function Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs Tetraspanin CD53: an overlooked regulator of immune cell function Tspan18 is a novel regulator of thrombo-inflammation Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations